These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 28272374)

  • 1. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
    Palmini G; Marini F; Brandi ML
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of microRNA in osteosarcoma and chondrosarcoma.
    Chang L; Shrestha S; LaChaud G; Scott MA; James AW
    Med Oncol; 2015 Jun; 32(6):613. PubMed ID: 25920607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA and Bone Cancer.
    Nugent M
    Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miRNAs in the pathgenesis of osteosarcoma.
    Liang W; Gao B; Fu P; Xu S; Qian Y; Fu Q
    Front Biosci (Landmark Ed); 2013 Jan; 18(2):788-94. PubMed ID: 23276964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental therapies and clinical trials in bone sarcoma.
    Chugh R
    J Natl Compr Canc Netw; 2010 Jun; 8(6):715-25. PubMed ID: 20581301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
    Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma.
    van Oosterwijk JG; Anninga JK; Gelderblom H; Cleton-Jansen AM; Bovée JV
    Hematol Oncol Clin North Am; 2013 Oct; 27(5):1021-48. PubMed ID: 24093174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic bone sarcomas: controversies and treatment options.
    Morris CD
    J Natl Compr Canc Netw; 2010 Jun; 8(6):731-7. PubMed ID: 20581302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
    Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
    Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Historical, current and future aspects of osteosarcoma treatment.
    Ham SJ; Schraffordt Koops H; van der Graaf WT; van Horn JR; Postma L; Hoekstra HJ
    Eur J Surg Oncol; 1998 Dec; 24(6):584-600. PubMed ID: 9870738
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
    Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
    Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
    Zhu Z; Wang CP; Zhang YF; Nie L
    Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNAs and bone tumours: Role of tiny molecules in the development and progression of chondrosarcoma, of giant cell tumour of bone and of Ewing's sarcoma.
    Palmini G; Brandi ML
    Bone; 2021 Aug; 149():115968. PubMed ID: 33892177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.
    Galoian KA; Guettouche T; Issac B; Qureshi A; Temple HT
    Tumour Biol; 2014 Mar; 35(3):2335-41. PubMed ID: 24178909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.
    Zhao H; Li M; Li L; Yang X; Lan G; Zhang Y
    PLoS One; 2013; 8(12):e83571. PubMed ID: 24391788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma.
    Ram Kumar RM; Boro A; Fuchs B
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma.
    Skipar P; Dey M; Piątkowski J; Sulejczak D; Rutkowski P; Czarnecka AM
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.
    Dai X; Ma W; He X; Jha RK
    Med Sci Monit; 2011 Aug; 17(8):RA177-190. PubMed ID: 21804475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.